Boston Partners
Institutional investor · Portfolio as of Q3 2022
Top Holdings721 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
JOHNSON & JOHNSON | 9M | $1.5B | 2.2% | $123.39 | +20.93% | 16 qtrssince 2018-Q4 | Decreased 0 |
AUTOZONE INC | 627,135 | $1.3B | 2.0% | $1,050.13 | +103.97% | 15 qtrssince 2019-Q1 | Decreased 0 |
CONOCOPHILLIPS | 12.6M | $1.3B | 1.9% | $39.66 | +134.68% | 16 qtrssince 2018-Q4 | Decreased 0 |
JPMORGAN CHASE & CO | 10.1M | $1.1B | 1.6% | $101.17 | -3.85% | 16 qtrssince 2018-Q4 | Increased 63 |
THE CIGNA GROUP | 3.4M | $940.9M | 1.4% | $179.22 | +47.70% | 16 qtrssince 2018-Q4 | Decreased 0 |
CENTENE CORP | 11.5M | $899.8M | 1.3% | $70.41 | +10.33% | 16 qtrssince 2018-Q4 | Decreased 0 |
SCHLUMBERGER LTD | 23.8M | $863.3M | 1.3% | $17.89 | +84.76% | 16 qtrssince 2018-Q4 | Increased 50 |
PIONEER NATURAL RESOURCE | 3.8M | $832.3M | 1.2% | — | — | 7 qtrssince 2021-Q1 | Decreased 0 |
ABBVIE INC | 6.2M | $827.3M | 1.2% | $94.04 | +23.65% | 16 qtrssince 2018-Q4 | Increased 51 |
UNITEDHEALTH GROUP INC | 1.6M | $815.5M | 1.2% | $304.77 | +57.57% | 16 qtrssince 2018-Q4 | Decreased 0 |
BERKSHIRE HATHAWAY INC-CL B | 3M | $799.4M | 1.2% | $207.52 | +29.91% | 16 qtrssince 2018-Q4 | Increased 53 |
MARATHON PETROLEUM CORP | 8M | $794.3M | 1.2% | $48.81 | +88.24% | 16 qtrssince 2018-Q4 | Decreased 0 |
CVS HEALTH CORPORATION | 8M | $766.8M | 1.1% | $70.23 | +17.62% | 16 qtrssince 2018-Q4 | Increased 57 |
SCHWAB (CHARLES) CORP | 10.4M | $747.5M | 1.1% | $48.01 | +41.50% | 16 qtrssince 2018-Q4 | Increased 65 |
ALPHABET INC-CL A | 7.6M | $728.6M | 1.1% | $96.30 | +0.41% | 16 qtrssince 2018-Q4 | Increased 80 |
BRISTOL-MYERS SQUIBB CO | 10.2M | $725.3M | 1.1% | $54.58 | +9.49% | 5 qtrssince 2021-Q3 | Increased 80 |
KEURIG DR PEPPER INC | 20.2M | $723M | 1.1% | $32.96 | +0.29% | 4 qtrssince 2021-Q4 | Increased 51 |
CENTERPOINT ENERGY INC | 25.1M | $706.3M | 1.0% | $17.77 | +48.99% | 11 qtrssince 2020-Q1 | Increased 52 |
AMERISOURCEBERGEN CORP | 5M | $684.6M | 1.0% | $81.07 | +62.49% | 16 qtrssince 2018-Q4 | Increased 55 |
EVEREST GROUP LTD | 2.6M | $681.9M | 1.0% | $218.60 | +15.85% | 16 qtrssince 2018-Q4 | Increased 48 |
Boston Partners manages $68.3B across 721 positions as of Q3 2022. Top holdings: JNJ (2.2%), AZO (2.0%), COP (1.9%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.
Active quarter - 72 new positions, 58 exits, 348 increased. Top move: GOOGL (INCREASED, conviction 80). Portfolio: $68.3B across 721 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer